Back to Results
First PageMeta Content
Immunosuppressants / Pharmaceutical sciences / Abatacept / Bristol-Myers Squibb / Rheumatoid arthritis / Adverse effect / Co-stimulation / Food and Drug Administration / Health / Medicine / Pharmacology


13 Orencia - FDA Presentation Slides
Add to Reading List

Open Document

File Size: 68,76 KB

Share Result on Facebook

Company

Bristol-Myers Squibb / /

Event

Product Recall / FDA Phase / Product Issues / /

MedicalCondition

adult rheumatoid arthritis / lung cancer / multiple sclerosis / lymphoma / acute lymphocytic leukemia / Hypersensitivity / varicella infection / infection / inflammation / ovarian cyst / infections / severely active polyarticular juvenile idiopathic arthritis / anaphylaxis / tuberculosis / hepatitis B / /

MedicalTreatment

Immunization / concomitant therapy / Immunosuppression / intravenous infusion / immunizations / /

Organization

Food and Drug Administration / Maternal Health Staff Office / Pediatric Advisory Committee / /

Person

Elizabeth L. Durmowicz / Pediatric Labeling / /

Position

Medical Officer / /

Product

Orencia / Randomized / Orencia® / /

SocialTag